Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Argus Health
Harvard Business School
Federal Trade Commission
Farmers Insurance
AstraZeneca
Medtronic
UBS
Express Scripts
Dow

Generated: January 23, 2019

DrugPatentWatch Database Preview

Drugs in Development Information for Lebrikizumab

« Back to Dashboard

US Patents for Lebrikizumab

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Lebrikizumab ➤ Try a Free Trial Compositions and methods for treating plasma cell disorders and B-cell prolymphocytic disorders Knopp Biosciences LLC (Pittsburgh, PA) ➤ Try a Free Trial
Lebrikizumab ➤ Try a Free Trial Nucleic acid comprising or coding for a histone stem-loop and a poly(A) sequence or a polyadenylation signal for increasing the expression of an encoded therapeutic protein CureVac AG (Tubingen, DE) ➤ Try a Free Trial
Lebrikizumab ➤ Try a Free Trial Nucleic acid comprising or coding for a histone stem-loop and a poly(A) sequence or a polyadenylation signal for increasing the expression of an encoded therapeutic protein CureVac AG (Tubingen, DE) ➤ Try a Free Trial
Lebrikizumab ➤ Try a Free Trial Delamination resistant pharmaceutical glass containers containing active pharmaceutical ingredients Corning Incorporated (Corning, NY) ➤ Try a Free Trial
Lebrikizumab ➤ Try a Free Trial Delamination resistant pharmaceutical glass containers containing active pharmaceutical ingredients Corning Incorporated (Corning, NY) ➤ Try a Free Trial
Lebrikizumab ➤ Try a Free Trial Compositions and methods for treating chronic urticaria Knopp Biosciences LLC (Pittsburgh, PA) ➤ Try a Free Trial
Drugname Patent Number Patent Title Patent Assignee Estimated Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

International Patents for Lebrikizumab

Drugname Country Document Number Estimated Expiration Related US Patent
Lebrikizumab Australia 2014287067 2033-07-12 ➤ Try a Free Trial
Lebrikizumab Australia 2014306597 2033-07-12 ➤ Try a Free Trial
Lebrikizumab Australia 2014306683 2033-07-12 ➤ Try a Free Trial
Lebrikizumab Australia 2017276231 2033-07-12 ➤ Try a Free Trial
Lebrikizumab Canada 2918035 2033-07-12 ➤ Try a Free Trial
Lebrikizumab Canada 2921378 2033-07-12 ➤ Try a Free Trial
Drugname Country Document Number Estimated Expiration Related US Patent

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Johnson and Johnson
US Army
Queensland Health
Accenture
Daiichi Sankyo
Cantor Fitzgerald
Chinese Patent Office
Argus Health
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.